Form 4: Medpace Holdings Executive Stephen Ewald Acquires Additional Shares
SEC Form 4 Filing
Stephen Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., reports purchasing 2 shares of common stock at $326.11 on February 27, 2025, increasing his holdings to 13,343 shares.
Summary
- On February 27, 2025, Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., acquired 2 shares of common stock.
- The purchase price was $326.11 per share.
- Following the transaction, Ewald directly owns 13,343 shares of Medpace Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, reflecting a standard transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares purchased by an executive.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of transaction: Stephen P. Ewald purchased 2 shares of common stock. |
| 02/28/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.